JP2005508937A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508937A5
JP2005508937A5 JP2003533858A JP2003533858A JP2005508937A5 JP 2005508937 A5 JP2005508937 A5 JP 2005508937A5 JP 2003533858 A JP2003533858 A JP 2003533858A JP 2003533858 A JP2003533858 A JP 2003533858A JP 2005508937 A5 JP2005508937 A5 JP 2005508937A5
Authority
JP
Japan
Prior art keywords
composition
itf
peptide
biologically active
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003533858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508937A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/031998 external-priority patent/WO2003030824A2/en
Publication of JP2005508937A publication Critical patent/JP2005508937A/ja
Publication of JP2005508937A5 publication Critical patent/JP2005508937A5/ja
Withdrawn legal-status Critical Current

Links

JP2003533858A 2001-10-05 2002-10-07 皮膚病変を治療するための方法および組成物 Withdrawn JP2005508937A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32767301P 2001-10-05 2001-10-05
PCT/US2002/031998 WO2003030824A2 (en) 2001-10-05 2002-10-07 Methods and compositions for treating dermal lesions

Publications (2)

Publication Number Publication Date
JP2005508937A JP2005508937A (ja) 2005-04-07
JP2005508937A5 true JP2005508937A5 (enExample) 2006-01-05

Family

ID=23277534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003533858A Withdrawn JP2005508937A (ja) 2001-10-05 2002-10-07 皮膚病変を治療するための方法および組成物

Country Status (8)

Country Link
US (1) US20030148949A1 (enExample)
EP (1) EP1438062A4 (enExample)
JP (1) JP2005508937A (enExample)
CN (1) CN1599619A (enExample)
AU (1) AU2002334886B2 (enExample)
CA (1) CA2462291A1 (enExample)
MX (1) MXPA04003267A (enExample)
WO (1) WO2003030824A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525018B1 (en) 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
AU2003224773B2 (en) * 2002-03-26 2010-08-26 The General Hospital Corporation Combination therapy using trefoil peptides
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
EP1587534A1 (en) * 2003-01-17 2005-10-26 Children's Hospital Medical Center Use of tff2, or agents inducing tff2, in the therapy of allergies
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
US8075771B2 (en) * 2005-02-17 2011-12-13 E. I. Du Pont De Nemours And Company Apparatus for magnetic field gradient enhanced centrifugation
CA2609259A1 (en) * 2005-05-27 2006-12-07 Johnson & Johnson Consumer Companies, Inc. Discrete patch for viral lesions
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
RU2497679C2 (ru) 2008-10-02 2013-11-10 Милан Инк. Способ получения многослойного клеящегося ламинированного материала
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2014042875A1 (en) * 2012-09-12 2014-03-20 Boston Scientific Scimed, Inc. Adhesive stent coating for anti-migration
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US20200179409A1 (en) * 2015-08-05 2020-06-11 Cmpd Licensing, Llc Topical compositions and methods of formulating the same
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN114518416B (zh) * 2020-11-20 2024-05-24 上海交通大学医学院附属瑞金医院 一种判断银屑病对il-17a抗体应答反应及其复发的标志物
PE20240888A1 (es) * 2020-12-08 2024-04-24 Imagine Pharma Llc Composiciones y metodos para tratar heridas

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370317A (en) * 1980-09-10 1983-01-25 Novo Industri A/S Pancreatic spasmolytic polypeptide
US5843701A (en) * 1990-08-02 1998-12-01 Nexstar Pharmaceticals, Inc. Systematic polypeptide evolution by reverse translation
US6063755A (en) * 1991-02-14 2000-05-16 The General Hospital Corporation Intestinal trefoil proteins
US6221840B1 (en) * 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
US5703047A (en) * 1992-09-21 1997-12-30 Board Of Regents, The University Of Texas System Methods and treatments for corneal healing with growth factors
DK6893D0 (da) * 1993-01-21 1993-01-21 Novo Nordisk As Peptid
US5563046A (en) * 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
US6426404B1 (en) * 1997-08-25 2002-07-30 The General Hospital Corporation Receptor for intestinal trefoil factor
FR2769502B1 (fr) * 1997-10-14 2000-04-14 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir du trefle (trifolium sp.)
US6228840B1 (en) * 1998-02-27 2001-05-08 Edward T. Wei Melanocortin receptor antagonists and modulations of melanocortin receptor activity
CZ293735B6 (cs) * 1998-08-26 2004-07-14 Smithkline Beecham Corporation Farmaceutický prostředek pro léčbu plicní nemoci
US6372439B2 (en) * 1998-10-01 2002-04-16 James R. Goldenring Screen for gastric adenocarcinoma
US6685917B2 (en) * 2000-11-22 2004-02-03 Rxkinetix, Inc. Treatment of mucositis
JP2004515235A (ja) * 2000-12-08 2004-05-27 ノボ ノルディスク アクティーゼルスカブ Ｔｆｆペプチド
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US7538082B2 (en) * 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
MXPA03009772A (es) * 2001-04-24 2004-02-23 Gen Hospital Corp Metodos y composiciones para tratar lesiones orales y del esofago.
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20030153496A1 (en) * 2001-06-14 2003-08-14 Lars Thim Mucosal repair by TFF dimer peptides
AU2002315234A1 (en) * 2001-06-14 2003-01-02 Novo Nordisk A/S Mucosal repair by tff2 peptides
WO2003011117A2 (en) * 2001-07-31 2003-02-13 The General Hospital Corporation Methods and compositions for treating and preventing distal bowel lesions
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
EP1461076A4 (en) * 2001-11-28 2005-03-09 Gen Hospital Corp METHOD AND COMPOSITIONS FOR TREATING LESIONS OF THE RESPIRATORY EPITHEL
US20030215431A1 (en) * 2002-02-11 2003-11-20 Lars Thim Management of mucosal viscosity by TFF monomer peptides
AU2003224773B2 (en) * 2002-03-26 2010-08-26 The General Hospital Corporation Combination therapy using trefoil peptides
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
WO2005039619A1 (en) * 2003-10-03 2005-05-06 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
US7575920B2 (en) * 2005-07-25 2009-08-18 The Gi Company, Inc. Yeast expression vectors for production of ITF

Similar Documents

Publication Publication Date Title
US6620435B1 (en) Compositions for topical application of therapeutic agents
AU2002334886B2 (en) Methods and compositions for treating dermal lesions
CN104994843B (zh) 用于创伤愈合的成膜药物组合物和用于制备其的方法
US20030185839A1 (en) Methods and compositions for treating dermal lesions
AU2002334886A1 (en) Methods and compositions for treating dermal lesions
CA2650825C (en) Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds
US20100196454A1 (en) Dressing formulations to prevent and reduce scarring
ES2318061T3 (es) Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
KR20070072482A (ko) 치료적 응용을 위한 유기겔 제제형
JP2001500863A5 (enExample)
CN102159198A (zh) 皮肤感染的局部治疗
US8409628B2 (en) Methods and compositions for oxygenation of skin to treat skin disorders
JP2011057709A5 (enExample)
CN101663039A (zh) 壳聚糖提高指甲生长速率的用途
CN101442987A (zh) 喷雾制剂和皮肤给药方法
WO2007070694A2 (en) Spray-on formulations and methods for dermal delivery of drugs
Thorburn et al. Topical corticosteroids and lesions of the oral mucosa
CN115887421B (zh) 一种复方糖皮质激素喷膜剂及其制备和应用
CN1750831A (zh) 痔疮治疗剂
ES2272416T3 (es) Preparaciones anhidras topicas para la piel.
EP3915568A1 (en) Mucoadhesive composition for use in the treatment of oral wound
AU768046B2 (en) Compositions and methods for topical application of therapeutic agents
Fiskerstrand et al. Weekly treatment of psoriasis vulgaris with corticosteroids and a hydrocolloid dressing is superior to the steroid alone or to UVB
AU695054B2 (en) Compounds for veterinary and medicinal applications
CN1913903A (zh) 病毒感染引起的皮肤和粘膜损伤的外用治疗剂